1. Home
  2. OMCL vs EOS Comparison

OMCL vs EOS Comparison

Compare OMCL & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • EOS
  • Stock Information
  • Founded
  • OMCL 1992
  • EOS 2005
  • Country
  • OMCL United States
  • EOS United States
  • Employees
  • OMCL N/A
  • EOS N/A
  • Industry
  • OMCL Computer Manufacturing
  • EOS Trusts Except Educational Religious and Charitable
  • Sector
  • OMCL Technology
  • EOS Finance
  • Exchange
  • OMCL Nasdaq
  • EOS Nasdaq
  • Market Cap
  • OMCL 1.3B
  • EOS 1.2B
  • IPO Year
  • OMCL 2001
  • EOS N/A
  • Fundamental
  • Price
  • OMCL $29.38
  • EOS $24.05
  • Analyst Decision
  • OMCL Buy
  • EOS
  • Analyst Count
  • OMCL 6
  • EOS 0
  • Target Price
  • OMCL $44.83
  • EOS N/A
  • AVG Volume (30 Days)
  • OMCL 525.9K
  • EOS 84.1K
  • Earning Date
  • OMCL 07-31-2025
  • EOS 01-01-0001
  • Dividend Yield
  • OMCL N/A
  • EOS 6.80%
  • EPS Growth
  • OMCL N/A
  • EOS N/A
  • EPS
  • OMCL 0.45
  • EOS N/A
  • Revenue
  • OMCL $1,135,755,000.00
  • EOS N/A
  • Revenue This Year
  • OMCL $3.84
  • EOS N/A
  • Revenue Next Year
  • OMCL $4.07
  • EOS N/A
  • P/E Ratio
  • OMCL $62.42
  • EOS N/A
  • Revenue Growth
  • OMCL 3.00
  • EOS N/A
  • 52 Week Low
  • OMCL $22.66
  • EOS $15.62
  • 52 Week High
  • OMCL $55.75
  • EOS $20.63
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 49.88
  • EOS 71.85
  • Support Level
  • OMCL $28.21
  • EOS $22.84
  • Resistance Level
  • OMCL $32.05
  • EOS $23.66
  • Average True Range (ATR)
  • OMCL 0.80
  • EOS 0.24
  • MACD
  • OMCL -0.06
  • EOS 0.02
  • Stochastic Oscillator
  • OMCL 38.62
  • EOS 98.37

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

Share on Social Networks: